• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类血吸虫病:疫苗接种的潜在后果

Human schistosomiasis: potential consequences of vaccination.

作者信息

Woolhouse M E

机构信息

Department of Zoology, University of Oxford, UK.

出版信息

Vaccine. 1995 Aug;13(12):1045-50. doi: 10.1016/0264-410x(95)00083-d.

DOI:10.1016/0264-410x(95)00083-d
PMID:7491810
Abstract

The potential outcomes of a Phase II schistosomiasis vaccine trial are explored using mathematical models which assume some natural immunity and a vaccine providing partial protection for a limited time. Analyses suggest that vaccination may have only a limited impact on life-long cumulative worm burdens and may lead to increased susceptibility and higher worm burdens at some ages, a "rebound" effect which results reduced opportunity to acquire natural immunity. There is a trade-off between the degree and duration of vaccine-induced protection; long-lived vaccines may be preferable to vaccines giving greater protection but for a shorter time.

摘要

利用数学模型探讨了二期血吸虫病疫苗试验的潜在结果,这些模型假定存在一定的自然免疫力以及一种能在有限时间内提供部分保护的疫苗。分析表明,接种疫苗可能仅对终生累积虫负荷产生有限影响,并且可能导致某些年龄段的易感性增加和虫负荷升高,即一种“反弹”效应,这会减少获得自然免疫力的机会。在疫苗诱导的保护程度和持续时间之间存在权衡;长效疫苗可能比提供更强但持续时间更短保护的疫苗更可取。

相似文献

1
Human schistosomiasis: potential consequences of vaccination.人类血吸虫病:疫苗接种的潜在后果
Vaccine. 1995 Aug;13(12):1045-50. doi: 10.1016/0264-410x(95)00083-d.
2
Quantitative assessment of the impact of partially protective anti-schistosomiasis vaccines.部分保护性抗血吸虫病疫苗影响的定量评估
PLoS Negl Trop Dis. 2017 Apr 14;11(4):e0005544. doi: 10.1371/journal.pntd.0005544. eCollection 2017 Apr.
3
Human schistosomiasis: potential long-term consequences of vaccination programmes.人类血吸虫病:疫苗接种计划的潜在长期后果
Vaccine. 1997 Oct;15(14):1545-50. doi: 10.1016/s0264-410x(97)00071-6.
4
Desirable characteristics of a schistosomiasis vaccine: some implications of a cost-effectiveness analysis.血吸虫病疫苗的理想特性:成本效益分析的若干启示
Acta Trop. 1995 Jun;59(3):197-209. doi: 10.1016/0001-706x(95)91938-5.
5
Progress towards a vaccine for schistosomiasis.血吸虫病疫苗的研发进展。
Acta Trop. 2003 May;86(2-3):309-13. doi: 10.1016/s0001-706x(03)00062-7.
6
Schistosomiasis vaccines: a devils' advocate view.血吸虫病疫苗:一种唱反调的观点。
Parasitol Today. 2000 Feb;16(2):46-8. doi: 10.1016/s0169-4758(99)01597-5.
7
Parameters of the attenuated schistosome vaccine evaluated in the olive baboon.在东非狒狒身上评估的减毒血吸虫疫苗的参数。
Infect Immun. 2004 Sep;72(9):5526-9. doi: 10.1128/IAI.72.9.5526-5529.2004.
8
Schistosomiasis vaccines: a response to a devils' advocate's view.血吸虫病疫苗:对质疑观点的回应
Parasitol Today. 2000 Aug;16(8):322-3. doi: 10.1016/s0169-4758(00)01711-7.
9
Development of a vaccine strategy against human and bovine schistosomiasis. Background and update.针对人类和牛血吸虫病的疫苗策略的发展。背景与最新情况。
Trop Geogr Med. 1994;46(4 Spec No):242-6.
10
Development of a vaccine strategy against human and bovine schistosomiasis. Background and update.
Mem Inst Oswaldo Cruz. 1995 Mar-Apr;90(2):235-40. doi: 10.1590/s0074-02761995000200019.

引用本文的文献

1
Sm-p80-Based Schistosomiasis Vaccine: Preparation for Human Clinical Trials.基于Sm-p80的血吸虫病疫苗:人类临床试验准备
Trends Parasitol. 2017 Mar;33(3):194-201. doi: 10.1016/j.pt.2016.10.010. Epub 2016 Nov 16.
2
Human Onchocerciasis: Modelling the Potential Long-term Consequences of a Vaccination Programme.人类盘尾丝虫病:疫苗接种计划潜在长期后果的建模
PLoS Negl Trop Dis. 2015 Jul 17;9(7):e0003938. doi: 10.1371/journal.pntd.0003938. eCollection 2015.
3
A research agenda for helminth diseases of humans: modelling for control and elimination.
人类寄生虫病研究议程:控制和消除寄生虫病的建模。
PLoS Negl Trop Dis. 2012;6(4):e1548. doi: 10.1371/journal.pntd.0001548. Epub 2012 Apr 24.
4
Human hookworm infection in the 21st century.21世纪的人体钩虫感染
Adv Parasitol. 2004;58:197-288. doi: 10.1016/S0065-308X(04)58004-1.